UCB SA Ownership
UCBJF Stock | USD 174.00 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
UCB |
UCB Pink Sheet Ownership Analysis
About 38.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.52. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. UCB SA last dividend was issued on the 29th of April 2022. UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. Ucb SA operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.The quote for UCB SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call JeanChristophe Tellier at 32 2 559 99 99 or visit https://www.ucb.com.Currently Active Assets on Macroaxis
Other Information on Investing in UCB Pink Sheet
UCB SA financial ratios help investors to determine whether UCB Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UCB with respect to the benefits of owning UCB SA security.